pharma · Chronic Hepatitis Delta Virus Infection · Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Huahui Health is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Hepatitis Delta Virus Infection, Advanced or Unresectable Hepatocellular Carcinoma (HCC). NovaPharmaNews links 2
Changping, CN HQ
3 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Changping, CN
- Employees
- 3
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Will receive HH-009 injection 20 mg/kg, Q3W
Phase 2 · small molecule · Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Will receive HH-009 injection 20 mg/kg, Q3W for Advanced or Unresectable Hepatocellular Carcinoma (HCC) is a Phase 2 program (small_molecule) at Huahui Health with 1 ClinicalTrials.gov record(s).
Internal code HH009-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Huahui Health
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced or Unresectable Hepatocellular Carcinoma (HCC)
- Status
- active
- Trials
- 1